Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm', 'lymphoma']
the pivotal phase data on #glofitamab are now online in #nejm, released simultaneously with our presentation of durability of crs beyond end of therapy at #ash22 this morning. a pleasure and a privilege to be part of this journey with and many others #lymsm 
Haemato-oncologist. Clinical researcher. Mostly lymphoma and phase 1 haematology studies.